Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer. Jouines C, Lo Monaco P, Gaucherot A, Radermecker J, et al. Breast Cancer Res 2025;27:202.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jouines C, Lo Monaco P, Gaucherot A, Radermecker J, et al. Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer. Breast Cancer Res 2025;27:202.
PMID: 41233923